Literature DB >> 17398137

Development of vaccines against Plasmodium falciparum malaria: taking lessons from naturally acquired protective immunity.

Lars Hviid1.   

Abstract

The acquisition of substantial anti-malarial protection in people naturally exposed to P. falciparum is often cited as evidence that malaria vaccines can be developed, but is rarely used to guide the development. We are pursuing the development of vaccines based on antigens and immune responses that appear key in naturally acquired protection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17398137     DOI: 10.1016/j.micinf.2007.02.008

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  4 in total

1.  Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy.

Authors:  Gaoqian Feng; Elizabeth Aitken; Francisca Yosaatmadja; Linda Kalilani; Steven R Meshnick; Anthony Jaworowski; Julie A Simpson; Stephen J Rogerson
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

2.  Within-host competition can delay evolution of drug resistance in malaria.

Authors:  Mary Bushman; Rustom Antia; Venkatachalam Udhayakumar; Jacobus C de Roode
Journal:  PLoS Biol       Date:  2018-08-21       Impact factor: 8.029

Review 3.  Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it.

Authors:  Anja Ramstedt Jensen; Yvonne Adams; Lars Hviid
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

Review 4.  What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity.

Authors:  Samson M Kinyanjui; Philip Bejon; Faith H Osier; Peter C Bull; Kevin Marsh
Journal:  Malar J       Date:  2009-10-28       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.